U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07700615) titled 'Mexidol(R) Efficacy and Safety in Treatment of VCIND in Older Adults' on July 07.
Brief Summary: The primary objective of this study is to evaluate the efficacy of Mexidol(R) sequential parenteral and oral administration as part of comprehensive therapy in older adults with chronic brain ischemia and vascular cognitive impairment, no dementia (VCIND).
Study Start Date: Sept. 14, 2025
Study Type: INTERVENTIONAL
Condition:
Vascular Cognitive Impairment no Dementia
Intervention:
DRUG: Mexidol
In addition to standard therapy, Mexidol sequential therapy was administered in two phases:
* Days 1 to 5: Intravenous (IV) infusion of 1...